Bone Densitometer Market

The increasing interest in bone density measurement, is a major driver for global bone densitometer market. A bone density test measures calcium and other minerals packed in a given bone segment. Weak bones decrease the ability to do daily activities and broken bones, particularly major breaks such as hip fractures, can cause disability and ongoing pain. Osteoporosis is a condition that causes bones to become thin and porous, decreasing bone strength and leading to increased risk of breaking a bone. As per Osteoporosis Canada, one in five men and one in three women are expected to suffer from osteoporotic fracture during their lifetime. In 2010, an estimated $2.3 billion as cost was borne by the Canadian Healthcare System in treating osteoporosis and the fractures it causes. 80% of all fractures in people aged above 50 years are caused by osteoporosis. Furthermore, the rise in aging population globally and the availability of improved treatments for preventing fractures are expected to propel the growth of the bone densitometer market.

The bone densitometers market is segmented into three broad categories: by technology, by end user, and by geography. The technology segmented into two broad classifications comprising axial bone densitometry and peripheral bone densitometry. The axial bone densitometry is sub segmented into dual energy X-ray absorptiometry and quantitative computed tomography, while the peripheral bone densitometry is sub segmented into single energy x-ray absorptiometry, dual energy x-ray absorptiometry, radiographic absorptiometry, quantitative ultrasound, and peripheral quantitative computed tomography. The end user is segmented into hospital based bone densitometers and clinic based bone densitometers.

Geographically, the bone densitometers market is segmented into North America, Europe, Asia and Rest of the World (RoW: Latin America, Pacific Countries, and Africa). North America and Europe are the mature markets for bone densitometers while the Asian region is expected to witness the highest growth in the forecast period (2014-2019).

Some of the key players in this market are BeamMed Ltd (Israel), Diagnostic Medical Systems S.A. (France), GE Healthcare (U.S.), Hologic, Inc. (U.S.), Osteometer Meditech Inc, (U.S.), Lone Oak Medical Technologies, LLC (U.S.), CooperSurgical, Inc, (U.S.), and CompuMed, Inc, (U.S.) amongst others.